Monitoring of Risedronate by biochemical bone markers in clinical practice.
The study of trend of Risedronate 10 mg/day in menopausal women with a high level of resorptive bone marker (Betacrosslaps, CTx) by the following bone markers:Bone alkaline phosphatase (formation marker) total alkaline phosphatase (TAlP), NMID osteocalcin, undercarboxylated osteocalcin (UcOC) and pr...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/16784 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.16784 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.167842018-06-21T15:22:05Z Monitoring of Risedronate by biochemical bone markers in clinical practice. Narong Bunyaratavej Mahidol University Medicine The study of trend of Risedronate 10 mg/day in menopausal women with a high level of resorptive bone marker (Betacrosslaps, CTx) by the following bone markers:Bone alkaline phosphatase (formation marker) total alkaline phosphatase (TAlP), NMID osteocalcin, undercarboxylated osteocalcin (UcOC) and procollagen type 1 carboxyl propeptides (PICP). Risedronate does not suppress bone resorption deeply that enhances the bone recovers quickly after withdrawal. The level of undercarboxylated osteocalcin was increased after one year of treatment; it may be a sign of vitamin K2 deficiency. The bone alkaline phosphatase was decreased at the end of 12 months and Procollagen type 1 carboxyl propeptides (PICP) of twelfth month changed significantly compared to the sixth months of treatment (p=0.001) The once week 70 mg/week group also changed of CTx the same as daily dose group. 2018-06-21T08:22:05Z 2018-06-21T08:22:05Z 2005-10-01 Article Journal of the Medical Association of Thailand = Chotmaihet thangphaet. Vol.88, No.suppl 5 (2005) 01252208 2-s2.0-34248592208 https://repository.li.mahidol.ac.th/handle/123456789/16784 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34248592208&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Medicine |
spellingShingle |
Medicine Narong Bunyaratavej Monitoring of Risedronate by biochemical bone markers in clinical practice. |
description |
The study of trend of Risedronate 10 mg/day in menopausal women with a high level of resorptive bone marker (Betacrosslaps, CTx) by the following bone markers:Bone alkaline phosphatase (formation marker) total alkaline phosphatase (TAlP), NMID osteocalcin, undercarboxylated osteocalcin (UcOC) and procollagen type 1 carboxyl propeptides (PICP). Risedronate does not suppress bone resorption deeply that enhances the bone recovers quickly after withdrawal. The level of undercarboxylated osteocalcin was increased after one year of treatment; it may be a sign of vitamin K2 deficiency. The bone alkaline phosphatase was decreased at the end of 12 months and Procollagen type 1 carboxyl propeptides (PICP) of twelfth month changed significantly compared to the sixth months of treatment (p=0.001) The once week 70 mg/week group also changed of CTx the same as daily dose group. |
author2 |
Mahidol University |
author_facet |
Mahidol University Narong Bunyaratavej |
format |
Article |
author |
Narong Bunyaratavej |
author_sort |
Narong Bunyaratavej |
title |
Monitoring of Risedronate by biochemical bone markers in clinical practice. |
title_short |
Monitoring of Risedronate by biochemical bone markers in clinical practice. |
title_full |
Monitoring of Risedronate by biochemical bone markers in clinical practice. |
title_fullStr |
Monitoring of Risedronate by biochemical bone markers in clinical practice. |
title_full_unstemmed |
Monitoring of Risedronate by biochemical bone markers in clinical practice. |
title_sort |
monitoring of risedronate by biochemical bone markers in clinical practice. |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/16784 |
_version_ |
1763488349136355328 |